Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 47, Status: Authorised
One Health approach
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 February 2026, 15:00 (CET) to 12 February 2026, 16:00 (CET)
European Medicines Agency (EMA) and European Alliance of Associations for Rheumatology (EULAR) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2026, 14:00 (CET) to 18 March 2026, 16:00 (CET)
We are pleased to announce that we opened the Call for the position of Editor-in-Chief of the European Journal of Internal Medicine, EJIM.
The Editor-in-Chief will assume responsibility for the scientific leadership and strategic development of the journal for a six-year term, beginning in January 2027.
EFIM seeks an internationally recognised expert in Internal Medicine with a strong academic background, editorial experience, and a clear vision for the continued growth and impact of EJIM.
The deadline for applications is 31 May 2026.
Medical devices
Report - Highlights of the 15th Industry Standing Group (ISG) meeting
Non-clinical development and evaluation of microbiome-based medicinal products - Scientific guideline
Draft concept paper on the development of a reflection paper on the non-clinical development and evaluation of microbiome-based medicinal products